Bioequivalence Study of Gabapentin 800 mg Tablets Under Fed Conditions
Status:
Completed
Trial end date:
2002-11-01
Target enrollment:
Participant gender:
Summary
This study compared the relative bioavailability (rate and extent of absorption) of
Gabapentin tablets 800 mg by Ranbaxy Laboratories Limited with that of Neurontin ® 800 mg
tablets of Parke Davis Pharmaceuticals Ltd. Distributed by Parke-Davis, division of
Warner-Lambert Co. following a single oral dose (1x800 mg tablet) in healthy adult volunteers
under non-fasting conditions.